Kettner A - Search Results

1

Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial.

Fellrath JM, Kettner A, Dufour N, Frigerio C, Schneeberger D, Leimgruber A, Corradin G, Spertini F. Fellrath JM, et al. Among authors: kettner a. J Allergy Clin Immunol. 2003 Apr;111(4):854-61. doi: 10.1067/mai.2003.1337. J Allergy Clin Immunol. 2003. PMID: 12704369 Clinical Trial.

2

Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study.

Spertini F, DellaCorte G, Kettner A, de Blay F, Jacobsen L, Jutel M, Worm M, Charlon V, Reymond C. Spertini F, et al. Among authors: kettner a. J Allergy Clin Immunol. 2016 Jul;138(1):162-8. doi: 10.1016/j.jaci.2016.02.044. Epub 2016 May 6. J Allergy Clin Immunol. 2016. PMID: 27373329 Clinical Trial.

3

Modulation of T-cell response to phospholipase A2 and phospholipase A2-derived peptides by conventional bee venom immunotherapy.

Kämmerer R, Chvatchko Y, Kettner A, Dufour N, Corradin G, Spertini F. Kämmerer R, et al. Among authors: kettner a. J Allergy Clin Immunol. 1997 Jul;100(1):96-103. doi: 10.1016/s0091-6749(97)70200-8. J Allergy Clin Immunol. 1997. PMID: 9257793

4

Delineation of PLA2 epitopes using short or long overlapping synthetic peptides: interest for specific immunotherapy.

Kämmerer R, Kettner A, Chvatchko Y, Dufour N, Tiercy JM, Corradin G, Spertini F. Kämmerer R, et al. Among authors: kettner a. Clin Exp Allergy. 1997 Sep;27(9):1016-26. doi: 10.1111/j.1365-2222.1997.tb01253.x. Clin Exp Allergy. 1997. PMID: 9678833

5

IgE and T-cell responses to high-molecular weight allergens from bee venom.

Kettner A, Henry H, Hughes GJ, Corradin G, Spertini F. Kettner A, et al. Clin Exp Allergy. 1999 Mar;29(3):394-401. doi: 10.1046/j.1365-2222.1999.00492.x. Clin Exp Allergy. 1999. PMID: 10202349

6

Allergen-derived long peptide immunotherapy down-regulates specific IgE response and protects from anaphylaxis.

von Garnier C, Astori M, Kettner A, Dufour N, Heusser C, Corradin G, Spertini F. von Garnier C, et al. Among authors: kettner a. Eur J Immunol. 2000 Jun;30(6):1638-45. doi: 10.1002/1521-4141(200006)30:6<1638::AID-IMMU1638>3.0.CO;2-R. Eur J Immunol. 2000. PMID: 10898500 Free article.

7

Inducing tolerance by intranasal administration of long peptides in naive and primed CBA/J mice.

Astori M, von Garnier C, Kettner A, Dufour N, Corradin G, Spertini F. Astori M, et al. Among authors: kettner a. J Immunol. 2000 Sep 15;165(6):3497-505. doi: 10.4049/jimmunol.165.6.3497. J Immunol. 2000. PMID: 10975871

8

Api m 6: a new bee venom allergen.

Kettner A, Hughes GJ, Frutiger S, Astori M, Roggero M, Spertini F, Corradin G. Kettner A, et al. J Allergy Clin Immunol. 2001 May;107(5):914-20. doi: 10.1067/mai.2001.113867. J Allergy Clin Immunol. 2001. PMID: 11344362

9

In vivo kinetics of the immunoglobulin E response to allergen: bystander effect of coimmunization and relationship with anaphylaxis.

Von Garnier C, Astori M, Kettner A, Dufour N, Corradin G, Spertini F. Von Garnier C, et al. Among authors: kettner a. Clin Exp Allergy. 2002 Mar;32(3):401-10. doi: 10.1046/j.1365-2222.2002.01304.x. Clin Exp Allergy. 2002. PMID: 11940071

10

Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season.

Kettner A, DellaCorte G, de Blay F, Jacobsen L, Jutel M, Worm M, Charlon V, Simonsen K, Reymond C, Spertini F. Kettner A, et al. J Allergy Clin Immunol. 2018 Aug;142(2):678-680.e7. doi: 10.1016/j.jaci.2018.01.052. Epub 2018 Apr 17. J Allergy Clin Immunol. 2018. PMID: 29678749 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

49 results

Search Page